MUVON Therapeutics is a clinical stage spin-off from the University of Zurich – founded on October 23rd 2020 – developing a highly innovative, single-use, injectable cell-based tissue engineering platform for the regeneration of skeletal muscle tissue with the aim of providing safe and effective treatments to millions of patients suffering from seriously debilitating diseases by not only repairing damaged tissue but also increase the regenerative potential of weakened muscles.